Vivek Kumar
Vivek Kumar has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Aditi Mohan
Petrichor Biologics Foundation, Ghaziabad, India
1 shared publication - Ajay Kumar Singh
Amity Foundation for Science, Technology and Innovation Alliances, Amity University, Noida, India
1 shared publication - Ashwani Koul
Panjab University
1 shared publication - Garima Gupta
Petrichor Biologics Foundation, Ghaziabad, India
1 shared publication - Nidhi Sandal
Division of CBRN Defence, Institute of Nuclear Medicine and Allied Sciences, Defence Research and Development Organization, Ministry of Defence, New Delhi, India
1 shared publication - Ravi Kumar
Petrichor Biologics Foundation, Ghaziabad, India
1 shared publication
Latest Publications
- Open Access
- 17 December 2024
- Published by Springer Nature in Discover Medicine
- Vol. 1 (1) , 1-26
Translational research in the generation of therapeutic medicine for wound healing: a review
Chronic wounds, such as diabetic ulcers, venous leg ulcers, and pressure sores, are among the most difficult to manage. Despite advancements in medical science, key clinical issues remain unresolved, particularly in addressing these persistent and complex wounds. Chronic wounds fail to follow the typical stages of healing due to impaired activation of various biological pathways. These conditions underscore the urgent need for more effective therapeutic options, as current treatments often fall short in promoting complete healing. The human wound healing process is a complex biological phenomenon involving the simultaneous activation of multiple molecular and cellular pathways. We systematically inspected databases for studies evaluating role of different growth factors, stem cell therapies and regenerative or wound healing medicine in wound healing and tissue regeneration. Regenerative medicine has focused on wound healing because of the accessibility, structure, and regenerative potential of the skin during the healing process. Furthermore, in order to acquire successful market access and widespread adoption, the effectiveness of new technologies should be evaluated based on their outcomes and the economic impact on healthcare. To fully harness the potential of regenerative medicine and wound healing therapies, it is essential to conduct rigorous studies that establish the safety and efficacy of new treatments for specific patient populations. This review explores these challenges and emphasizes how regenerative medicine, with its focus on utilizing biological mechanisms to repair damaged tissues, presents a promising path forward. By examining the roles of various growth factors, stem cell therapies, and emerging regenerative treatments, the review delves into their impact on wound healing and tissue regeneration. Moreover, it highlights key molecular pathways and therapeutic targets that could be leveraged to improve outcomes, potentially overcoming the limitations of existing approaches. Graphical Abstract
- 17 December 2024
- Published by Springer Nature in Discover Medicine
- Vol. 1 (1) , 1-26
Open AccessTranslational research in the generation of therapeutic medicine for wound healing: a review
Chronic wounds, such as diabetic ulcers, venous leg ulcers, and pressure sores, are among the most difficult to manage. Despite advancements in medical science, key clinical issues remain unresolved, particularly in addressing these persistent and complex wounds. Chronic wounds fail to follow the typical stages of healing due to impaired activation of various biological pathways. These conditions underscore the urgent need for more effective therapeutic options, as current treatments often fall short in promoting complete healing. The human wound healing process is a complex biological phenomenon involving the simultaneous activation of multiple molecular and cellular pathways. We systematically inspected databases for studies evaluating role of different growth factors, stem cell therapies and regenerative or wound healing medicine in wound healing and tissue regeneration. Regenerative medicine has focused on wound healing because of the accessibility, structure, and regenerative potential of the skin during the healing process. Furthermore, in order to acquire successful market access and widespread adoption, the effectiveness of new technologies should be evaluated based on their outcomes and the economic impact on healthcare. To fully harness the potential of regenerative medicine and wound healing therapies, it is essential to conduct rigorous studies that establish the safety and efficacy of new treatments for specific patient populations. This review explores these challenges and emphasizes how regenerative medicine, with its focus on utilizing biological mechanisms to repair damaged tissues, presents a promising path forward. By examining the roles of various growth factors, stem cell therapies, and emerging regenerative treatments, the review delves into their impact on wound healing and tissue regeneration. Moreover, it highlights key molecular pathways and therapeutic targets that could be leveraged to improve outcomes, potentially overcoming the limitations of existing approaches. Graphical Abstract
- 24 May 2023
- Published by Springer Nature in BioMetals
- Vol. 36 (5) , 1125-1140
In vitro and in vivo removal efficacy of insoluble Prussian blue in combination with calcium polystyrene sulfonate for thallium
The similarities between thallium and potassium have suggested the use of calcium polystyrene sulfonate (CPS), an oral ion exchange resin, as a potential agent against thallium intoxication. Therefore, the study was an attempt to evaluate the efficacy of CPS and Prussian blue when given alone or in combination against thallium toxicity. The effect on binding capacity was investigated in terms of contact time, amount of CPS, influence of pH, simulated physiological solutions and interference of potassium ions. Also, rats were given single dose of thallium chloride (20 mg kg−1) and the treatment with PB and CPS was given for 28 days as CPS 30 g kg−1, orally, twice a day, PB 3 g kg−1, orally, twice a day and their combination. The effect of antidotal treatment was evaluated by calculating the thallium levels in various organs, blood, urine and feces. The results of the in vitro study indicated exceedingly quick binding in the combination of CPS and PB as compared to PB alone. Also, it was found that the binding capacity at pH 2.0 was considerably increased for PB with CPS (184.656 mg g−1) as compared to PB (37.771 mg g−1). Furthermore, statistically significant results were obtained in the in vivo study as after 7th day, thallium levels in blood of rats treated with combination were reduced by 64% as compared to control group and 52% as compared to alone PB treated group. Also, Tl retention in liver, kidney, stomach, colon and small intestine of combination treated rats was significantly reduced to 46%, 28%, 41%, 32% and 33% respectively, as compared to alone PB treated group. These findings demonstrate this as a good antidotal option against thallium intoxication.
- 24 May 2023
- Published by Springer Nature in BioMetals
- Vol. 36 (5) , 1125-1140
In vitro and in vivo removal efficacy of insoluble Prussian blue in combination with calcium polystyrene sulfonate for thallium
The similarities between thallium and potassium have suggested the use of calcium polystyrene sulfonate (CPS), an oral ion exchange resin, as a potential agent against thallium intoxication. Therefore, the study was an attempt to evaluate the efficacy of CPS and Prussian blue when given alone or in combination against thallium toxicity. The effect on binding capacity was investigated in terms of contact time, amount of CPS, influence of pH, simulated physiological solutions and interference of potassium ions. Also, rats were given single dose of thallium chloride (20 mg kg−1) and the treatment with PB and CPS was given for 28 days as CPS 30 g kg−1, orally, twice a day, PB 3 g kg−1, orally, twice a day and their combination. The effect of antidotal treatment was evaluated by calculating the thallium levels in various organs, blood, urine and feces. The results of the in vitro study indicated exceedingly quick binding in the combination of CPS and PB as compared to PB alone. Also, it was found that the binding capacity at pH 2.0 was considerably increased for PB with CPS (184.656 mg g−1) as compared to PB (37.771 mg g−1). Furthermore, statistically significant results were obtained in the in vivo study as after 7th day, thallium levels in blood of rats treated with combination were reduced by 64% as compared to control group and 52% as compared to alone PB treated group. Also, Tl retention in liver, kidney, stomach, colon and small intestine of combination treated rats was significantly reduced to 46%, 28%, 41%, 32% and 33% respectively, as compared to alone PB treated group. These findings demonstrate this as a good antidotal option against thallium intoxication.